주식/증권 ➡️ 중립

CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing

Yahoo Finance 09/08/2026 10:28:02 PM 42회

요약

Compass has said a rolling FDA application is already underway for its COMP360, with the package due to be completed in the fourth quarter of 2026 and a possible U.S. launch in the first half of 2027.

원문 기사 보기

관련 뉴스

Fund managers won't dump stocks for bonds until yields hit 5.9%, BofA survey says: Chart of the Day

10/13/2026

Gold’s upside outweighs downside risks as markets face oil, France uncertainty

10/13/2026

Kimberly-Clark wins EU conditional approval for $40B purchase of Kenvue

10/13/2026

J&J shares down despite guidance raise as MedTech revenues disappoint

10/13/2026

뉴스 목록으로